Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single vs Multiple Injections for Axillary Plexus Block
NCT03378323Phase 4Completed
- Sponsor
- Hôpital du Valais
- Start
- Jul 2018
- Primary completion
- Apr 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine, mepivacaine in pain, sponsored by Hôpital du Valais. Started Jul 2018; status: completed.
02
Drugs
ropivacainemepivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03378323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03378323.